European Medicines Agency (EMA) | What's new Follow Orphan designation: 3-(3-(3,5-Dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid Treatment of ATTR amyloidosis, 19/11/2018 Withdrawn https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-18-2081 ema.europa.eu
